TY  - GEN
AU  - Vilain,Ricardo E
AU  - Menzies,Alexander M
AU  - Wilmott,James S
AU  - Kakavand,Hojabr
AU  - Madore,Jason
AU  - Guminski,Alexander
AU  - Liniker,Elizabeth
AU  - Kong,Benjamin Y
AU  - Cooper,Adam J
AU  - Howle,Julie R
AU  - Saw,Robyn P M
AU  - Jakrot,Valerie
AU  - Lo,Serigne
AU  - Thompson,John F
AU  - Carlino,Matteo S
AU  - Kefford,Richard F
AU  - Long,Georgina V
AU  - Scolyer,Richard A
TI  - Dynamic Changes in PD-L1 Expression and Immune Infiltrates Early During Treatment Predict Response to PD-1 Blockade in Melanoma
SN  - 1557-3265
PY  - 2018///0619
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - B7-H1 Antigen
KW  - antagonists & inhibitors
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Biopsy
KW  - CD8-Positive T-Lymphocytes
KW  - immunology
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Immunotherapy
KW  - Kaplan-Meier Estimate
KW  - Lymphocytes, Tumor-Infiltrating
KW  - drug effects
KW  - Male
KW  - Melanoma
KW  - drug therapy
KW  - Middle Aged
KW  - Nivolumab
KW  - Programmed Cell Death 1 Receptor
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1158/1078-0432.CCR-16-0698
ER  -